WHAT CAN WE SAY ABOUT POT AND AUTISM?

bDavid G. Evans, Esq., Senior Counsel, Cannabis Industry Victims Educating Litigators (CIVEL) –

Marijuana use makes autism scores worse. Autism Spectrum Disease (ASD) “is the commonest form of cannabis-associated clinical teratology.” (exhibits 1 and 2 ). A tetralogy is a collection of four things having something in common, such as a deformity with four features.

This is likely epidemiologically highly significant for the US, where autistic spectrum disorders have been shown to be growing exponentially. Cannabis use across the US was shown to be independently associated with autism rates across both time and space, to be dose-related, and, based on conservative projections, has been predicted to be at least 60% higher in cannabis-legal states than in states where cannabis was illegal by 2030. (exhibit 3)

Being particularly vulnerable to the pro-psychotic effects of cannabinoid exposure, autism spectrum individuals present with an increased risk of psychosis, which may be passed on to their own children. (exhibit 4)

Conclusion

Use of marijuana products can make autism scores worse in the user.

Exhibit 1.

Effect of Cannabis Legalization on US Autism Incidence and Medium-Term Projections. Reece AS and Hulse GK. Clinical Pediatrics. Vol 4, Iss 2, No:154

https://www.longdom.org/open-access/effect-of-cannabis-legalization-on-us-autism-incidence-and-medium-term-projections.pdf

Exhibit 2.

In a study, 3,080 young adult Australian twins were used to assess ADHD symptoms, autistic traits, substance use, and substance use disorders. Great ADHD symptoms and autistic traits scores were associated with elevated levels of cannabis use and cannabis use disorder. DeAkwis D, et al. ADHD Symptoms, Autistic Traits, and Substance Use and Misuse in Adult Australian Twins. Journal of Studies on Alcohol and Drugs, March 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965675/

Exhibit 3

Epidemiological Association of Various Substances and Multiple Cannabinoids with Autism in the USA. Reese SA and Hulse GK. Clinical Pediatrics., Vol 4, Issue2, No: 155.

Cannabinoids with Autism in USA. Accepted 22nd May 2019.  Clinical Pediatrics: Open Access. Published 31st May 2019.  https://www.longdom.org/open-access/epidemiological-associations-of-various-substances-and-multiple-cannabinoids-with-autism-in-usa.pdf

Exhibit 4.

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
Riccardo Bortoletto 1,2, Marco Colizzi 2,3,*
Healthcare (Basel). 2022 Aug 16;10(8):1553. doi: 10.3390/healthcare10081553
PMCID: PMC9407973  PMID: 36011210
https://pmc.ncbi.nlm.nih.gov/articles/PMC9407973/

 

David G. Evans, Esq.

Senior Counsel

Cannabis Industry Victims Educating Litigators (CIVEL)

203 Main St. Suite 149

Flemington, NJ 08822

908-963-0254

www.civel.org

 

DISCLAIMER OF LIABILITY IN CONNECTING YOU WITH AN ATTORNEY

 

If we have connected you with an attorney this does not mean that we recommend this attorney as to their ability to help you or that we have investigated their ability. It only means that this attorney is interested in hearing about your case. There have been no representations or guarantees made regarding the outcome of this matter as to the obtaining of any award for damages, judgment, or any other aspect of this matter.

 

PRIVACY

This e-mail transmission is protected by state law and the Federal Electronic Communications Privacy Act, 18 U.S.C. Sections 2510-2521 and is intended to be delivered only to the named addressee(s) and may contain information that is confidential, proprietary, attorney work-product or attorney-client privileged. If this information is received by anyone other than the named addressee(s), the recipient should immediately notify the David G. Evans, Esq. by e-mail or by telephone 908-963-0254 and obtain instructions as to the disposal of the transmitted material. In no event shall this material be read, used, copied, reproduced, stored or retained by anyone other than the named addressee(s), except with the express consent of Mr. Evans or the named addressee(s). Receipt of this email does not waive any legal privilege

DISCLAIMER OF LEGAL ADVICE

This should not be considered legal advice. This is for informational purposes only. Use of and access to these materials does not in itself create an attorney – client relationship between David G. Evans and CIVEL and the user or reader. Mr. Evans or CIVEL cannot vouch for any study cited herein since they did not do the study. The readers should consult the study and make their own interpretation as to its accuracy. Please also be advised that case law and statutory and regulatory laws cited herein may have been amended or changed by the time you read this.

IRS Circular 230 Disclosure:

To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein.

Source: www.civel.org

Back to top of page

Powered by WordPress